MarginsXMarginsX
Home › Markets › Health Care › MDWD

MediWound Ltd. (MDWD)

MDWD trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$13.55
+5.04% on the day
Market cap
$195.0M
Micro cap
Revenue · 2025
$17.0M
-16.1% on 2024
Net income · 2025
-$23.9M
-140.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1593984/000117891326000749/0001178913-26-000749-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMDWD on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryIsrael
IPO year2014
SEC CIK0001593984
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inIsrael

Financials · 2025

LineValue
Revenue$17.0M
Net income-$23.9M
Operating income-$25.3M
Net margin-140.8%
Operating margin-149.0%
Revenue growth-16.1%
Cash$4.8M
Total assets$86.3M
P/E (computed)Net income was not positive
P/S (computed)11.5×

Warning signs

Cash runway
3.6 months
$4.8M cash at December 31, 2025
Share count, 1 year
+18.9%
2024-12-31 to 2025-12-31 · +77.3% over 3 years
Going-concern doubt
No
20-F filed March 5, 2026
Insider net buying, 12 months
$61K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-05
Cash and burn$4.8M cash; operating cash flow -$4.0M a quarter.Report 2025-12-31
Shares outstanding12,835,148 (2025-12-31); 10,793,057 a year earlier; 7,240,020 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-11-05
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorSomekh Chaikin, Tel Aviv, IsraelPCAOB Form AP 2026-03-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $143K, sold $82K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$17.0M-$23.9M-$16.1M$4.8MNo debt tags$17.0M20-F 2026-03-05
FY 2024
2024-12-31
$20.2M-$30.2M-$13.6M$9.2MNo debt tags$20.2M20-F 2026-03-05
FY 2023
2023-12-31
$18.7M-$6.7M-$10.5M$11.9MNo debt tags$18.7M20-F 2026-03-05
FY 2022
2022-12-31
$26.5M-$19.6M-$11.9M$33.9MNo debt tags$26.5M20-F 2025-03-19
FY 2021
2021-12-31
$23.8M-$13.6M-$8.9M$11.0MNo debt tags$23.8M20-F 2024-03-21
FY 2020
2020-12-31
$21.8M-$9.2M-$6.9M$17.4MNo debt tags$21.8M20-F 2023-03-16
FY 2019
2019-12-31
$31.8M$5.0M$8.3M$7.2MNo debt tags$31.8M20-F 2022-03-17
FY 2018
2018-12-31
$3.4M-$1.1M-$12.2M$6.7MNo debt tags$3.4M20-F 2021-02-25

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-11-05
Latest annual report20-F2026-03-05
Latest quarterly / interim6-K2026-11-12

Source: SEC EDGAR submissions feed, 402 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-9.5%
1 month+5.6%
3 months-4.7%
Year to date-30.1%
1 year-29.8%
From 52-week high-33.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
NAGENiagen Bioscience Inc.$2.01-2.66%$159.2M
USNAUSANA Health Sciences Inc.$13.54+2.27%$250.3M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M
GLASGlass House Brands Inc. Subordinate Voting Shares$1.29+1.57%$113.5M
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M
ISPRIspire Technology Inc.$1.52-10.06%$87.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier